Congratulations to Dr. ElMallah and her team for receiving an award for a project entitled A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP-9001 in Non-Ambulatory and Ambulatory Subjects with Duchenne Muscular Dystrophy (ENVISION). Sarepta Therapeutics. 08/08/2023-03/12/2026